SymbolISPC
NameISPECIMEN INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Commercial Physical & Biological Resarch
Address450 BEDFORD STREET, LEXINGTON, Massachusetts, 02420, United States
Telephone+1 781 301-6700
Fax
Email
Websitehttps://www.ispecimen.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001558569
Description

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. Its iSpecimen Marketplace platform solves this problem and transforms the biospecimen procurement process to accelerate medical discovery. Geographically, it has a presence in the Americas; Europe, Middle East, and Africa, and Asia Pacific.

Additional info from NASDAQ:
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. Its iSpecimen Marketplace platform solves this problem and transforms the biospecimen procurement process to accelerate medical discovery. Geographically, it has a presence in the Americas; Europe, Middle East, and Africa, and Asia Pacific.

2026-05-14 17:50

New Form D - iSpecimen Inc. <b>Filed:</b> 2026-05-14 <b>AccNo:</b> 0001213900-26-056752 <b>Size:</b> 9 KB

Read more
2026-05-13 21:00

(35% Negative) ISPECIMEN INC. (ISPC) Announces Business Combination

Read more
2026-05-13 02:04

ISPC attributes changed: Attr: Fin_status D -> N;

Read more
2026-05-13 02:04

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Read more
2026-05-13 01:49

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Read more
2026-05-09 01:04

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

Read more
2026-05-09 01:04

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

Read more
2026-05-01 21:00

(99% Neutral) ISPECIMEN INC. (ISPC) Announces Business Combination

Read more
2026-04-24 13:00

iSpecimen Announces 1-for-40 Reverse Stock Split

Read more
2026-04-10 20:05

(99% Positive) ISPECIMEN INC. (ISPC) Files Form 8-K

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT03884400 Distribution of Biospecimens From Biorepositories/Biobanks for Research Use Cancer Withdrawn 2021-01-01 2026-03-01 ClinicalTrials.gov
NCT05080907 Collection and Distribution of Biospecimens for Novel Research Cancer Unknown 2016-07-15 2025-01-01 ClinicalTrials.gov
NCT03848962 Collection and Distribution of Biospecimens for Novel Research Uses Cancer Recruiting 2016-06-30 2026-12-31 ClinicalTrials.gov
Total clinical trials: 3
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Observational Other Preclinical Cancer UNKNOWN NCT05080907
Specimens obtained from surgical, phlebotomy or other non-invasive procedure Procedure Preclinical Cancer WITHDRAWN NCT03884400
Observational OTHER Preclinical Cancer UNKNOWN NCT05080907
Specimens obtained from surgical, phlebotomy or other non-invasive procedure PROCEDURE Preclinical Cancer WITHDRAWN NCT03884400
Total products: 4